Global life science investment firm Novo Holdings on Thursday announced a direct investment in KKR-backed fungal biotechnology solutions developer Sylvan.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
